A Phase 2 Study of Sorafenib in Patients With Metastatic Renal Cell Carcinoma at Stanford University ClinicalTrials.gov
ID: NCT00854620
Description: Determine time-to-progression (TTP) for an escalating dose schedule for subjects with progressive metastatic renal cell carcinoma treated with s...
A Phase II/III Randomized Trial of Two Doses of MK-3475 (SCH900475) Versus Docetaxel in Previously Treated Subjects With Non-Small Cell Lung Cancer ClinicalTrials.gov
ID: NCT01905657
Description: This study compared two doses of pembrolizumab (MK-3475) versus docetaxel in participants with non-small cell lung cancer (NSCLC) who had experi...
Phase II, Randomized, Double-blind, Multi-centered Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia (HGPIN) or Atypica... ClinicalTrials.gov
ID: NCT00596011
Description: The purpose of this study was to determine whether the daily consumption of decaffeinated green tea catechins (Polyphenon E®) for 1 year reduce...
XERAD: Open-Label, Phase II, Randomized, Comparative, Multicentre Trial of Concurrent Whole Brain Radiation Therapy (WBRT) and Capecitabine (Xeloda®)... ClinicalTrials.gov
ID: NCT00977379
Description: This open-label, randomized, parallel arm study will evaluate the effect of capecitabine administered concurrently with WBRT and as maintenance ...
An Open-label, Multicentre, Nonrandomized, Dose-escalating Phase I/II Study, With a Randomized Phase II Part, to Investigate the Safety and Tolerabili... ClinicalTrials.gov
ID: NCT00517530
Description: The primary objective for the phase I part of the study is to investigate the safety and tolerability of escalating intravenous (IV) doses of ob...
A Phase 1, Randomized, Double-blind, Placebo-controlled, 3- Period, Crossover Study To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmaco... ClinicalTrials.gov
ID: NCT02292433
Description: Study B1621018 will assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Dose Levels of Pf-04937319 in Japanese Subjec...
A Phase II, Multicenter, Randomized, Placebo -Controlled, Study To Evaluate The Efficacy and Safety Of Intramuscular Peramivir 600 mg In Subjects With... ClinicalTrials.gov
ID: NCT00705406
Description: The purpose of this study is to determine whether peramivir is safe and effective in the treatment of uncomplicated seasonal influenza.
A Multicenter, Randomized, Open Label, Parallel-group Phase IIB Study on the Efficacy and Safety of Oral Regimens of DEB025 Alone or in Combination Wi... ClinicalTrials.gov
ID: NCT01215643
Description: The study is to investigate whether alisporivir (ALV; DEB025) alone or in combination with either ribavirin (RBV) or peginterferon alfa-2a (PEG)...
A Prospective, Multicenter, Double-Blinded, Randomized Study to Evaluate Bleeding Patterns in Women Using One of Three Different Doses of DR-1031 Oral... ClinicalTrials.gov
ID: NCT00394771
Description: This is a 4-arm study to evaluate and compare bleeding patterns between three different doses of DR-1031 oral contraceptive with Seasonale oral ...
Effects of 12 Weeks of Omega 3 Supplementation on Resting Metabolic Rate ClinicalTrials.gov
ID: NCT02092649
Description: Fatty acids are the main components of the cell membranes. It has been demonstrated that diet can alter the characteristics and function of many...
A Phase I/II Open-label Study of the Effects of Anakinra in Corticosteroid-resistant Subjects With Autoimmune Inner Ear Disease ClinicalTrials.gov
ID: NCT01267994
Description: The purpose of this study is to determine if Anakinra (an interleukin-1 receptor antagonist) can improve hearing thresholds in those patients wi...
A Pilot Study of the Physiologic Effects of Using the Breathe Technologies Noninvasive Open Ventilation System During Constant Work Rate Exercise in S... ClinicalTrials.gov
ID: NCT01372462
Description: Pilot study in 15 stable male subjects with severe-to-very severe Chronic Obstructive Pulmonary Disease (COPD) to evaluate the effects of short ...
Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery ClinicalTrials.gov
ID: NCT00701636
Description: This investigation is a prospective, open-label pharmacokinetic study of daptomycin prophylaxis in patients undergoing coronary artery bypass gr...